Schonfeld Strategic Advisors LLC Harrow Health, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $15.4 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$20.85 - $46.47 $323,654 - $721,353
15,523 New
15,523 $697,000
Q1 2023

May 15, 2023
BUY
$13.84 - $21.46 $210,105 - $325,784
15,181 New
15,181 $321,000
Q3 2022

Nov 14, 2022
BUY
$6.57 - $24.88 $75,555 - $286,120
11,500 New
11,500 $139,000

Others Institutions Holding HROW

# of Institutions
185
Shares Held
21.1M
Call Options Held
679K
Put Options Held
1.27M
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $660M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email